The Amino Asylum FDA Record: A Dossier
Updated August 21, 2026
Amino Asylum's verified federal record, as compiled by this index, contains one entry: the FDA raid of its warehouse on or around June 18, 2025. It contains no warning letter to the company, no charges, and no court outcome. The Kawa and Stechkober guilty pleas often attached to the name belong to Paradigm Peptides.
Dossier
| Item | Status in this index's verified record |
|---|---|
| FDA warehouse raid | Documented. On or around June 18, 2025 — the first physical raid of a major vendor in this market's record |
| Site availability | Documented. Unreachable within roughly a day of the raid |
| Payment processing | Documented. Terminated in the same window |
| Open orders | Documented. Frozen, with no wind-down notice in the sourced accounts |
| Traffic at the time | Estimate. About 400,000 monthly visitors per third-party measurement tooling — modeled, not audited, and labeled accordingly |
| FDA warning letter to Amino Asylum | None captured in the verified record |
| Charges against the company or its operators | None in the verified record |
| Guilty pleas or convictions | None in the verified record — see the misattribution note below |
| Verified relaunch | None in the record as of August 21, 2026 |
The single documented event
Federal action against research-peptide sellers through 2024 arrived as correspondence: agency letters stating findings and opening a response window, as in the four-vendor batch of December 10, 2024. The Amino Asylum raid put a different instrument on record — agents at a facility, commerce ending the same day, no response window. The event is recorded in detail at the Amino Asylum raid record, and its position among the dated actions of 2024–2026 at the enforcement timeline.
What absence means here
This index publishes only what traces to a named source. "Not in the verified record" is a statement about this record — it is not a finding that the thing never happened, and it is not an exoneration. What it does mean is that no reader should repeat the absent items as fact. For Amino Asylum, the items most often repeated as fact are precisely the ones the record lacks: a warning letter, charges, pleas, a conviction, a relaunch.
The misattribution
Secondary coverage of the vendor shutdowns of 2024–2026 regularly attaches the guilty pleas of Matthew Kawa and Jennifer Stechkober to Amino Asylum. Those pleas — entered December 10, 2025, with sentencing on July 30, 2026 — belong to the prosecution of a different company, Paradigm Peptides, and are recorded at the Paradigm Peptides case record. During this index's own compilation, two machine-generated search summaries attributed the same names to both companies; the error is common enough that this dossier states the correction plainly rather than leaving it implicit. A row-by-row separation of the two records is maintained at the Amino Asylum vs. Paradigm comparison page.
Standing of this dossier
Amino Asylum's summary entry sits in the vendor index alongside the other vendor records. Buyers the shutdown displaced — the practical audience for this dossier — can find the index's supplier-verification framework at the Amino Asylum alternatives criteria page. If a verified court outcome, agency letter, or relaunch enters the record, the dossier table above changes and the dateline moves; nothing is added to it on the strength of secondary summaries.
Sources
- PS Peptides — vendor-industry account of the raid and its aftermath
- The Peptide Catalog — contemporaneous account of the closure
- CBS News — Paradigm Peptides sentencing report (basis for the misattribution correction)
How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.